Impact of NR5A2 and RYR2 3′UTR polymorphisms on the risk of breast cancer in a Chinese Han population Ying WeiXiaolin WangXinhan Zhao Review 23 June 2020 Pages: 1 - 8
A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer Rachel StarkingsValerie ShillingLesley Fallowfield Review Open access 23 June 2020 Pages: 9 - 21
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer Michelle D. HackshawHeather E. DanyshCharles A. Powell Review Open access 26 June 2020 Pages: 23 - 39
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer Yoshiya HorimotoNoriko SasaharaMitsue Saito Preclinical study 22 June 2020 Pages: 41 - 48
Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer Rashmi VermaAndrew M. HanbyThomas A. Hughes Preclinical study Open access 23 June 2020 Pages: 49 - 59
Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer Fang-Ming ChenLi-Ju HuangMing-Feng Hou Preclinical study 29 June 2020 Pages: 61 - 70
CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA Xiaowei YangLu ZhaoBenzhong Wang Preclinical study 29 June 2020 Pages: 71 - 82
Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema Paula M. C. DonahueRachelle CrescenziManus J. Donahue Preclinical study 29 June 2020 Pages: 83 - 94
Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers Dingxie Liu Preclinical study 29 June 2020 Pages: 95 - 105
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer Ahrong HamMin Hwan KimJoohyuk Sohn Clinical trial 23 June 2020 Pages: 107 - 116
Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study Hadeer G. KhalefaMay A. ShawkiLamia M. El Wakeel Clinical trial 29 June 2020 Pages: 117 - 125
Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy George E. NaoumOluwadamilola T. OladeruAlphonse G. Taghian Clinical trial 30 June 2020 Pages: 127 - 136
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer Vincent WalterChiara FischerMarkus Wallwiener Clinical trial Open access 01 July 2020 Pages: 137 - 144
Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery Elyse LeeVanBe Thi HoJeannie Shen Clinical trial 01 July 2020 Pages: 145 - 151
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study Sixten HarborgUffe Heide-JørgensenSigne Borgquist Epidemiology Open access 22 June 2020 Pages: 153 - 160
Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score Stephanie RobertsonBalazs AcsJohan Hartman Epidemiology Open access 22 June 2020 Pages: 161 - 175
Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study Lidia StaszewskyFabio RobustoRoberto Latini Epidemiology 25 June 2020 Pages: 177 - 188
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management Marianna CavazzaHelen BanksFrancesco Longo Epidemiology 26 June 2020 Pages: 189 - 199
Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data Melissa K. AccordinoJason D. WrightDawn L. Hershman Epidemiology 26 June 2020 Pages: 201 - 211
Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China Jing YaoYanfang LiuJing Cheng Epidemiology 27 June 2020 Pages: 213 - 216
Association between selenium intake and breast cancer risk: results from the Women’s Health Initiative Dan GuoMichael HendryxJuhua Luo Epidemiology 30 June 2020 Pages: 217 - 226
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer Diana G. WangDulce M. BarriosMario E. Lacouture Epidemiology 29 June 2020 Pages: 227 - 237
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer Marta PerachinoFrancesca PoggioMatteo Lambertini Letter to the Editor 28 June 2020 Pages: 239 - 240
A case for Tamoxifen with ovarian function suppression Pallavi KopparthyKaren Daily Letter to the Editor 29 June 2020 Pages: 241 - 242